diaziquone has been researched along with Leukemia, Myeloid, Acute in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, EJ; Reck, K; Schiffer, CA | 1 |
| Bell, B; Castleberry, R; Cushing, B; Falletta, JM; Krance, RA; Lauer, S; Mahoney, DH | 1 |
| Amrein, PC; Davis, RB; Mayer, RJ; Schiffer, CA | 1 |
| Meyers, PA; Redner, A; Steinherz, PG; Tan, CT | 1 |
| Lyman, GH; Raney, M; Vogler, WR | 1 |
1 trial(s) available for diaziquone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Continuous-infusion diaziquone in acute myeloid leukemia: a Southeastern Cancer Study Group trial.
Topics: Adult; Aziridines; Azirines; Benzoquinones; Bone Marrow; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 1987 |
4 other study(ies) available for diaziquone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Blast Crisis; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: a CALGB phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis; Time Factors | 1990 |
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male | 1989 |